Journal of Toxicology, published by HINDAWI LTD, stands as a pivotal open-access journal in the fields of toxicology and pharmacology since its inception in 2009. With an ISSN of 1687-8191 and an E-ISSN of 1687-8205, this journal is dedicated to disseminating high-quality research that critically examines the effects of toxic substances on living organisms. Located in Egypt and operating from their London office, it aims to provide an extensive platform for researchers worldwide to share findings that can inform better practices in safety and regulation. As of 2023, it has achieved significant recognition, holding a Q3 ranking in both the pharmacology and toxicology categories, and is indexed in Scopus with noteworthy percentile rankings (Toxicology: 57th and Pharmacology: 55th). With a focus on innovative studies and emerging areas such as environmental toxicology, biomarker research, and therapeutic interventions, the Journal of Toxicology invites both experienced researchers and students to contribute, thereby enhancing the breadth and depth of toxicological knowledge for the global scientific community.

TOXICON is a prominent peer-reviewed journal dedicated to advancing the field of toxicology and its related disciplines. Published by PERGAMON-ELSEVIER SCIENCE LTD, this journal has been a crucial resource for researchers since its inception in 1962, with a focus on disseminating high-quality research until 2024 and beyond. TOXICON features comprehensive studies spanning the biochemical, biochemical, and regulatory aspects of toxology, making it essential for researchers, professionals, and students alike. With a current impact factor that places it in the Q3 category of Toxicology and a Scopus rank of 67 out of 133 in its field, it serves as a valuable platform for innovative findings and discussions. Although it does not offer open access options, TOXICON's rigorous editorial standards ensure that published work meets the highest scholarly criteria, thereby enhancing its contribution to toxicological science.

Welcome to Dose-Response, a premier open-access journal published by SAGE Publications Inc., dedicated to advancing the understanding of dose-response relationships in chemical exposure, health, toxicology, and public health. Established in 2003, this journal has quickly become an invaluable resource for researchers and professionals in the fields of public health, environmental science, and toxicology, boasting a commendable impact factor and a notable ranking in multiple categories, including Q2 in Public Health and Environmental and Occupational Health. With its converged years stretching from 2008 to 2024, Dose-Response aims to publish high-quality articles that contribute to the evaluation of health risks and benefits, ensuring that essential research reaches a global audience. Its open-access model provides unrestricted access to groundbreaking studies, fostering collaborative efforts among scientists and practitioners to inform policy and improve public health outcomes.

The Journal of Venomous Animals and Toxins including Tropical Diseases, published by CEVAP-São Paulo State University (UNESP), is a premier open-access journal that has been disseminating vital research since its inception in 2003. This journal, holding a notable Q2 ranking in Animal Science and Zoology and Q3 rankings in Infectious Diseases, Parasitology, and Toxicology, serves as a critical platform for scholars and practitioners interested in the complex interactions between venomous animals, toxins, and tropical diseases. With an E-ISSN of 1678-9199, it offers broad accessibility to groundbreaking findings, particularly within its converged years of 2006 to 2024. By addressing pertinent issues that lie at the intersection of zoology, medicine, and environmental science, the journal aims to foster innovative research and stimulate discourse among researchers, students, and professionals committed to understanding and combating the threats posed by venomous species and their associated toxins. The journal's commitment to excellence is evidenced by its diversified metrics, including substantial rankings in Scopus, affirming its significance in the scientific community.

Antioxidants is a premier open-access journal published by MDPI that has been actively contributing to the field of antioxidant research since its inception in 2012. Based in Switzerland, the journal holds a noteworthy impact factor indicative of its scholarly influence, particularly given its high rankings in various categories. As of 2023, it proudly sits in the Q1 quartile in Biochemistry, Clinical Biochemistry, Food Science, and Physiology, solidifying its status as a critical resource for innovative studies. With a strong focus on the roles of antioxidants across multiple disciplines—ranging from molecular biology to food science—this journal serves as a vital platform for researchers, professionals, and students aiming to advance knowledge in mitigating oxidative stress and enhancing health through dietary and therapeutic approaches. The open-access model guarantees wide accessibility, allowing for the dissemination of significant research findings globally, making it indispensable for anyone engaged in modern biochemical and physiological studies.

CELL BIOLOGY AND TOXICOLOGY, published by SPRINGER, stands as a vital journal within the realms of cell biology and toxicology, boasting an impressive 2023 Q1 ranking in its fields, alongside robust Scopus rankings placing it in the top 11th percentile for Toxicology and the 22nd for Health, Toxicology and Mutagenesis. With an ISSN of 0742-2091 and an E-ISSN of 1573-6822, the journal has been a cornerstone of scientific discourse since its inception in 1984, and will continue to converge innovative research until 2024. The journal focuses on the interplay between cellular mechanisms and toxicological implications, making it an essential resource for researchers, healthcare professionals, and students keen on advancing their understanding of these critical areas. Although it does not offer open access, its high impact and prestigious standing ensure that its publications reach a wide audience dedicated to significant advancements in the life sciences.

Toxicon-X is a prestigious journal published by ELSEVIER, specializing in the dynamic field of toxicology. With an impact factor indicative of its excellence and rigor—ranked Q1 in Toxicology as of 2023, and positioned at #40 out of 133 in Scopus's Pharmacology, Toxicology, and Pharmaceutics category—this journal is a vital resource for researchers, practitioners, and students alike. Since its inception in 2019, Toxicon-X has embraced an Open Access model, enhancing accessibility and transparency of research findings. This ensures that crucial studies on toxic agents and their effects reach a broader audience, driving advancements in public health and safety. The journal is based in the United Kingdom and caters to a diverse international readership, with its scope encompassing novel research, reviews, and insights into emerging toxicological challenges. As we move towards the 2024 convergence year, Toxicon-X remains committed to fostering a deeper understanding of toxic substances, their mechanisms, and implications for human and environmental health.

JOURNAL OF APPLIED TOXICOLOGY, published by Wiley, stands as a leading platform in the field of toxicology, focusing on the rigorous examination of chemical substances and their effects on biological systems. With an impressive Impact Factor, it ranks in the top quartile (Q2) for toxicology journals, reflecting its esteemed position within the scientific community. The journal, identifiable by its ISSN 0260-437X and E-ISSN 1099-1263, has been an invaluable resource since its inception in 1981, and it continues to serve as a conduit for innovative research and practical applications through 2024. Positioned at the forefront of the field, it garners recognition in the Scopus Rankings, where it ranks #31 out of 133 journals in the toxicology category, placing it in the 77th percentile—a testament to its contribution to the advancement of pharmacology and toxicological sciences. While not an open-access journal, it remains accessible to a wide audience of researchers, professionals, and students eager to explore cutting-edge findings in applied toxicology, making it a pivotal resource for enhancing knowledge and fostering collaboration in the field.

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.

Comparative Biochemistry and Physiology C-Toxicology & Pharmacology, published by Elsevier Science Inc, stands as a prominent resource in the fields of pharmacology, toxicology, and biochemical research. With its ISSN 1532-0456 and E-ISSN 1878-1659, this journal has carved out a significant niche, focusing on the comparative aspects of biochemical and physiological data across various species. Recognized for its impact in diverse fields, it boasts a Q1 ranking in Animal Science and Zoology, Aquatic Science, Health, Toxicology and Mutagenesis, alongside respectable standings in other related disciplines. Researchers and professionals can leverage this publication to access high-quality, peer-reviewed studies that advance the understanding of biochemical processes and their toxicological implications. The journal aims to bridge the gap between laboratory findings and real-world applications, fostering an environment for interdisciplinary collaboration. For academics seeking to enhance their knowledge or contribute to this impactful field, Comparative Biochemistry and Physiology C-Toxicology & Pharmacology serves as an invaluable platform.